Omnimmune Holdings, Inc.
Other OTCTotal Valuation
Omnimmune Holdings, Inc. carries a market capitalization of 981.00, placing it among publicly traded companies globally. Its enterprise value stands at 2.28M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 981.00 |
| Enterprise Value | 2.28M |
Share Statistics
Omnimmune Holdings, Inc. currently has 9.36M shares outstanding.
| Shares Outstanding | 9.36M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Omnimmune Holdings, Inc. maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -39.95, indicating conservative leverage, while an interest coverage ratio of -2.98 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.01 |
| Quick Ratio | 0.00 |
| Debt / Equity | -39.95 |
| Debt / EBITDA | -1.71 |
| Interest Coverage | -2.98 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -4,535.18 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Income Statement
EBITDA reached -1.34M, while operating income came in at -1.34M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -1.34M |
| Pretax Income | -1.33M |
| Net Income | -1.79M |
| EBITDA | -1.34M |
| EBIT | -1.34M |
| Earnings Per Share (EPS) | -0.20 |
Balance Sheet
Omnimmune Holdings, Inc. holds 4,805.00 in cash and equivalents against 2.28M in total debt, resulting in a net debt position of 2.28M. Total book value stands at -22.43M, with working capital of -4.67M providing operational flexibility.
| Cash & Cash Equivalents | 4,805.00 |
| Total Debt | 2.28M |
| Net Debt | 2.28M |
| Equity (Book Value) | -22.43M |
| Book Value Per Share | -2.49 |
| Working Capital | -4.67M |
Cash Flow
Omnimmune Holdings, Inc. produced -569,466.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -569,466.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -569,466.00 |
| FCF Per Share | -0.06 |
Stock Splits
Omnimmune Holdings, Inc.'s most recent stock split took place on July 1, 2008 with a 1:3 split ratio.
| Last Split Date | 7/1/2008 |
| Split Ratio | 1:3 |
Scores
Omnimmune Holdings, Inc. posts an Altman Z-Score of -951.49, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -951.49 |